Provided by Tiger Trade Technology Pte. Ltd.

RenovoRx Inc

1.37
-0.0200-1.44%
Post-market: 1.400.0300+2.19%18:38 EDT
Volume:590.01K
Turnover:795.89K
Market Cap:61.72M
PE:-4.42
High:1.41
Open:1.35
Low:1.28
Close:1.39
52wk High:2.59
52wk Low:0.7006
Shares:45.05M
Float Shares:39.17M
Volume Ratio:1.28
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3096
EPS(LYR):-0.3161
ROE:-125.23%
ROA:-64.90%
PB:6.87
PE(LYR):-4.33

Loading ...

RenovoRx Advances Tamp™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated Prism-Tamp Trial

THOMSON REUTERS
·
Yesterday

Here's Why We're Watching RenovoRx's (NASDAQ:RNXT) Cash Burn Situation

Simply Wall St.
·
Yesterday

RenovoRx announces publication on TAMP platform’s potential

TIPRANKS
·
Oct 01

RenovoRx Cites Peer-Reviewed Case Series on TAMP Gemcitabine Delivery in Locally Advanced Pancreatic Cancer

Reuters
·
Oct 01

RenovoRx to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 02

RenovoRx price target raised to $14.50 from $14 at Ascendiant

TIPRANKS
·
Aug 28

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

GlobeNewswire
·
Aug 25

RenovoRx regains compliance with Nasdaq

TIPRANKS
·
Aug 21

RenovoRx Regains Compliance with NASDAQ Minimum Bid Price Requirement

THOMSON REUTERS
·
Aug 21

RenovoRx Earnings Call: Record Growth, Rising Risks

TIPRANKS
·
Aug 21

RenovoRx Regains NASDAQ Compliance with $1 Minimum Bid Price Rule

Reuters
·
Aug 21

RenovoRx Gets USPTO Notice of Allowance for New RenovoCath Cancer Drug-Delivery Patent

Reuters
·
Aug 20

RenovoRx - Receives Uspto Notice of Allowance for Renovocath Patent Application

THOMSON REUTERS
·
Aug 20

Analyst Justin Walsh Reiterates Buy on RenovoRx After Strong 2Q26 Beat, Guidance Raise and Confirms $8 Price Target on TAMP Platform Momentum

TIPRANKS
·
Aug 20

Cancer Diagnostics Firm Precipio's Q2 Revenue Rises, Adjusted Ebitda Turns Positive

Reuters
·
Aug 15

Milestone Scientific Q2 Revenue Rises 22% on Medical Segment Growth, Reaffirms 2026 Outlook

Reuters
·
Aug 14

Sensus Healthcare Q2 Revenue Misses Estimates as Unit Sales Fall

Reuters
·
Aug 14

CapsoVision Q2 Revenue Rises on CapsoCam Plus Capsules Sales

Reuters
·
Aug 14

Tenon Medical Q2 Revenue Jumps on Higher Surgical Procedure Volume

Reuters
·
Aug 14

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 13